25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd
Buy, Hold or Sell?

Let's analyze Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd together

I guess you are interested in Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd

I send you an email if I find something interesting about Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd.

1. Quick Overview

1.1. Quick analysis of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.06
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥8.90
Expected worth in 1 year
¥8.87
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
¥0.37
Return On Investment
3.3%

For what price can you sell your share?

Current Price per Share
¥11.39
Expected price per share
¥11.04 - ¥13.00
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (5 min.)




Live pricePrice per Share (EOD)
¥11.39

2.2. Growth of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (5 min.)




Is Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$252.4m$251.5m-$2.4m-1.0%

How much money is Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd making?

Current yearPrevious yearGrowGrow %
Making money$1.6m$1m$578.4k35.1%
Net Profit Margin1.0%0.9%--

How much money comes from the company's main activities?

2.3. Financial Health of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (5 min.)




2.4. Comparing to competitors in the Pharmaceutical Retailers industry (5 min.)




  Industry Rankings (Pharmaceutical Retailers)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd?

Welcome investor! Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's management wants to use your money to grow the business. In return you get a share of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd.

First you should know what it really means to hold a share of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd. And how you can make/lose money.

Speculation

The Price per Share of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd is ¥11.39. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥8.90. Based on the TTM, the Book Value Change Per Share is ¥-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.16 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.10 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.010.1%0.010.1%0.010.0%0.010.1%0.010.1%
Usd Book Value Change Per Share0.000.0%0.000.0%0.020.2%0.121.1%0.121.1%
Usd Dividend Per Share0.020.1%0.010.1%0.010.1%0.010.1%0.010.1%
Usd Total Gains Per Share0.020.2%0.010.1%0.030.3%0.131.2%0.131.2%
Usd Price Per Share1.24-1.53-1.98-1.95-1.95-
Price to Earnings Ratio37.60-61.43--24.58-25.41-25.41-
Price-to-Total Gains Ratio65.49-63.20-162.96-104.31-104.31-
Price to Book Ratio1.01-1.27-1.62-1.64-1.64-
Price-to-Total Gains Ratio65.49-63.20-162.96-104.31-104.31-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.563847
Number of shares639
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share0.000.12
Usd Total Gains Per Share0.010.13
Gains per Quarter (639 shares)8.1684.58
Gains per Year (639 shares)32.65338.33
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
135-32326312328
270-55652625666
3106-889789371004
4141-1012210412501342
5176-1315513015621680
6211-1518815618742018
7246-1822118121872356
8281-2025420724992694
9317-2328723328123032
10352-2532025931243370

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%9.01.00.090.0%9.01.00.090.0%9.01.00.090.0%9.01.00.090.0%
Book Value Change Per Share2.02.00.050.0%6.04.00.060.0%6.04.00.060.0%6.04.00.060.0%6.04.00.060.0%
Dividend per Share4.00.00.0100.0%10.00.00.0100.0%10.00.00.0100.0%10.00.00.0100.0%10.00.00.0100.0%
Total Gains per Share3.01.00.075.0%9.01.00.090.0%9.01.00.090.0%9.01.00.090.0%9.01.00.090.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.028-0.007+126%0.162-83%0.890-97%0.890-97%
Book Value Per Share--8.9028.784+1%8.870+0%8.712+2%8.712+2%
Current Ratio--1.3111.286+2%1.584-17%1.586-17%1.586-17%
Debt To Asset Ratio--0.6980.682+2%0.560+25%0.586+19%0.586+19%
Debt To Equity Ratio--2.4092.224+8%1.373+75%1.601+50%1.601+50%
Dividend Per Share--0.1100.100+10%0.062+79%0.074+49%0.074+49%
Enterprise Value---2391922466.670-1605731343.050-33%597906434.888-500%135298803.110-1868%135298803.110-1868%
Eps--0.0600.058+3%0.038+59%0.057+6%0.057+6%
Ev To Ebitda Ratio--infinfnan%infnan%infnan%infnan%
Ev To Sales Ratio---0.453-0.328-28%0.162-379%0.133-441%0.133-441%
Free Cash Flow Per Share---0.236-0.265+12%-0.768+226%-0.578+146%-0.578+146%
Free Cash Flow To Equity Per Share---0.236-0.265+12%-0.768+226%-0.578+146%-0.578+146%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Market Cap2339540261.120+20%1864746471.0002299440969.500-19%2975747137.000-37%2925566251.900-36%2925566251.900-36%
Net Profit Margin--0.0090.010-5%0.009+3%0.013-28%0.013-28%
Operating Margin----0%-0%-0%-0%
Operating Ratio--1.7681.790-1%1.827-3%1.814-3%1.814-3%
Pb Ratio1.279+21%1.0141.270-20%1.625-38%1.637-38%1.637-38%
Pe Ratio47.433+21%37.60561.426-39%-24.585+165%25.414+48%25.414+48%
Price Per Share11.390+21%9.03011.135-19%14.410-37%14.167-36%14.167-36%
Price To Free Cash Flow Ratio-12.088-26%-9.584-3.309-65%-6.854-28%-5.943-38%-5.943-38%
Price To Total Gains Ratio82.602+21%65.48763.203+4%162.963-60%104.310-37%104.310-37%
Quick Ratio--0.6340.604+5%0.761-17%0.777-18%0.777-18%
Return On Assets--0.0020.002-2%0.002+6%0.003-28%0.003-28%
Return On Equity--0.0070.007+3%0.004+56%0.007+4%0.007+4%
Total Gains Per Share--0.1380.093+48%0.224-38%0.964-86%0.964-86%
Usd Book Value--252404817.795249051606.718+1%251503650.416+0%247020841.689+2%247020841.689+2%
Usd Book Value Change Per Share--0.004-0.001+126%0.022-83%0.122-97%0.122-97%
Usd Book Value Per Share--1.2221.206+1%1.218+0%1.196+2%1.196+2%
Usd Dividend Per Share--0.0150.014+10%0.008+79%0.010+49%0.010+49%
Usd Enterprise Value---328410954.674-220466913.401-33%82092553.510-500%18576525.667-1868%18576525.667-1868%
Usd Eps--0.0080.008+3%0.005+59%0.008+6%0.008+6%
Usd Free Cash Flow---6678918.003-7510689.181+12%-21777612.270+226%-16399486.546+146%-16399486.546+146%
Usd Free Cash Flow Per Share---0.032-0.036+12%-0.105+226%-0.079+146%-0.079+146%
Usd Free Cash Flow To Equity Per Share---0.032-0.036+12%-0.105+226%-0.079+146%-0.079+146%
Usd Market Cap321218877.852+20%256029690.468315713245.112-19%408570081.910-37%401680246.386-36%401680246.386-36%
Usd Price Per Share1.564+21%1.2401.529-19%1.978-37%1.945-36%1.945-36%
Usd Profit--1702119.3281645784.991+3%1067360.177+59%1609892.708+6%1609892.708+6%
Usd Revenue--181193793.417162502529.791+12%125845356.368+44%134498924.499+35%134498924.499+35%
Usd Total Gains Per Share--0.0190.013+48%0.031-38%0.132-86%0.132-86%
 EOD+5 -3MRQTTM+27 -10YOY+21 -165Y+19 -1810Y+19 -18

3.3 Fundamental Score

Let's check the fundamental score of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1547.433
Price to Book Ratio (EOD)Between0-11.279
Net Profit Margin (MRQ)Greater than00.009
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.634
Current Ratio (MRQ)Greater than11.311
Debt to Asset Ratio (MRQ)Less than10.698
Debt to Equity Ratio (MRQ)Less than12.409
Return on Equity (MRQ)Greater than0.150.007
Return on Assets (MRQ)Greater than0.050.002
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.744
Ma 20Greater thanMa 5011.829
Ma 50Greater thanMa 10011.658
Ma 100Greater thanMa 20010.524
OpenGreater thanClose12.160
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd

Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd engages in the wholesale and retail of pharmaceuticals products in China. The company offers anabolic preparations and peptide hormones, second-class psychotropic drugs, vaccines, antibiotic raw materials, biological products, biochemical drugs, antibiotic preparations, Chinese medicine decoction pieces, chemical drug preparations, chemical raw materials, Chinese herbal medicines, Chinese patent medicines, and medical toxic drugs; medical devices; and health food products. It also provides pharmaceutical logistics services; and operates reproductive hospitals. The company was formerly known as Hunan Tongjian Pharmacy CO., LTD and changed its name to Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd in August 2016. The company was founded in 2002 and is based in Changsha, China.

Fundamental data was last updated by Penke on 2024-12-03 11:29:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is not making a profit/loss.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd to the Pharmaceutical Retailers industry mean.
  • A Net Profit Margin of 0.9% means that ¥0.01 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd:

  • The MRQ is 0.9%. The company is not making a profit/loss.
  • The TTM is 1.0%. The company is not making a profit/loss.
Trends
Current periodCompared to+/- 
MRQ0.9%TTM1.0%0.0%
TTM1.0%YOY0.9%+0.1%
TTM1.0%5Y1.3%-0.3%
5Y1.3%10Y1.3%0.0%
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9%0.8%+0.1%
TTM1.0%0.7%+0.3%
YOY0.9%1.0%-0.1%
5Y1.3%1.7%-0.4%
10Y1.3%1.6%-0.3%
4.3.1.2. Return on Assets

Shows how efficient Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd to the Pharmaceutical Retailers industry mean.
  • 0.2% Return on Assets means that Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd generated ¥0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd:

  • The MRQ is 0.2%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.2%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.2%TTM0.2%0.0%
TTM0.2%YOY0.2%+0.0%
TTM0.2%5Y0.3%-0.1%
5Y0.3%10Y0.3%0.0%
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2%0.4%-0.2%
TTM0.2%0.4%-0.2%
YOY0.2%0.3%-0.1%
5Y0.3%0.5%-0.2%
10Y0.3%0.3%0.0%
4.3.1.3. Return on Equity

Shows how efficient Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd to the Pharmaceutical Retailers industry mean.
  • 0.7% Return on Equity means Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd generated ¥0.01 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd:

  • The MRQ is 0.7%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 0.7%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.7%TTM0.7%+0.0%
TTM0.7%YOY0.4%+0.2%
TTM0.7%5Y0.7%+0.0%
5Y0.7%10Y0.7%0.0%
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7%1.3%-0.6%
TTM0.7%1.0%-0.3%
YOY0.4%1.7%-1.3%
5Y0.7%1.9%-1.2%
10Y0.7%1.2%-0.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd is operating .

  • Measures how much profit Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd to the Pharmaceutical Retailers industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.1%-0.1%
TTM-0.5%-0.5%
YOY-1.6%-1.6%
5Y-1.7%-1.7%
10Y-1.8%-1.8%
4.3.2.2. Operating Ratio

Measures how efficient Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Pharmaceutical Retailers industry mean).
  • An Operation Ratio of 1.77 means that the operating costs are ¥1.77 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd:

  • The MRQ is 1.768. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.790. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.768TTM1.790-0.022
TTM1.790YOY1.827-0.037
TTM1.7905Y1.814-0.024
5Y1.81410Y1.8140.000
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7681.493+0.275
TTM1.7901.223+0.567
YOY1.8271.146+0.681
5Y1.8141.174+0.640
10Y1.8141.170+0.644
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Pharmaceutical Retailers industry mean).
  • A Current Ratio of 1.31 means the company has ¥1.31 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd:

  • The MRQ is 1.311. The company is just able to pay all its short-term debts.
  • The TTM is 1.286. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.311TTM1.286+0.025
TTM1.286YOY1.584-0.298
TTM1.2865Y1.586-0.299
5Y1.58610Y1.5860.000
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3111.241+0.070
TTM1.2861.256+0.030
YOY1.5841.181+0.403
5Y1.5861.358+0.228
10Y1.5861.522+0.064
4.4.3.2. Quick Ratio

Measures if Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd to the Pharmaceutical Retailers industry mean.
  • A Quick Ratio of 0.63 means the company can pay off ¥0.63 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd:

  • The MRQ is 0.634. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.604. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.634TTM0.604+0.030
TTM0.604YOY0.761-0.157
TTM0.6045Y0.777-0.174
5Y0.77710Y0.7770.000
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6340.493+0.141
TTM0.6040.546+0.058
YOY0.7610.629+0.132
5Y0.7770.657+0.120
10Y0.7770.892-0.115
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd to Pharmaceutical Retailers industry mean.
  • A Debt to Asset Ratio of 0.70 means that Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd assets are financed with 69.8% credit (debt) and the remaining percentage (100% - 69.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd:

  • The MRQ is 0.698. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.682. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.698TTM0.682+0.017
TTM0.682YOY0.560+0.122
TTM0.6825Y0.586+0.095
5Y0.58610Y0.5860.000
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6980.644+0.054
TTM0.6820.679+0.003
YOY0.5600.692-0.132
5Y0.5860.640-0.054
10Y0.5860.601-0.015
4.5.4.2. Debt to Equity Ratio

Measures if Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd to the Pharmaceutical Retailers industry mean.
  • A Debt to Equity ratio of 240.9% means that company has ¥2.41 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd:

  • The MRQ is 2.409. The company is just not able to pay all its debts with equity.
  • The TTM is 2.224. The company is just not able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ2.409TTM2.224+0.186
TTM2.224YOY1.373+0.850
TTM2.2245Y1.601+0.622
5Y1.60110Y1.6010.000
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4091.693+0.716
TTM2.2242.030+0.194
YOY1.3732.191-0.818
5Y1.6011.982-0.381
10Y1.6011.664-0.063
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd generates.

  • Above 15 is considered overpriced but always compare Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd to the Pharmaceutical Retailers industry mean.
  • A PE ratio of 37.60 means the investor is paying ¥37.60 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd:

  • The EOD is 47.433. Based on the earnings, the company is overpriced. -1
  • The MRQ is 37.605. Based on the earnings, the company is overpriced. -1
  • The TTM is 61.426. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD47.433MRQ37.605+9.828
MRQ37.605TTM61.426-23.821
TTM61.426YOY-24.585+86.010
TTM61.4265Y25.414+36.012
5Y25.41410Y25.4140.000
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
EOD47.43316.385+31.048
MRQ37.60515.792+21.813
TTM61.42612.431+48.995
YOY-24.58511.917-36.502
5Y25.4148.474+16.940
10Y25.41416.030+9.384
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd:

  • The EOD is -12.088. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -9.584. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.309. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-12.088MRQ-9.584-2.505
MRQ-9.584TTM-3.309-6.275
TTM-3.309YOY-6.854+3.546
TTM-3.3095Y-5.943+2.635
5Y-5.94310Y-5.9430.000
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
EOD-12.0882.561-14.649
MRQ-9.5842.516-12.100
TTM-3.3092.666-5.975
YOY-6.8540.223-7.077
5Y-5.9432.853-8.796
10Y-5.9430.315-6.258
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Pharmaceutical Retailers industry mean).
  • A PB ratio of 1.01 means the investor is paying ¥1.01 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd:

  • The EOD is 1.279. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.014. Based on the equity, the company is underpriced. +1
  • The TTM is 1.270. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.279MRQ1.014+0.265
MRQ1.014TTM1.270-0.256
TTM1.270YOY1.625-0.354
TTM1.2705Y1.637-0.366
5Y1.63710Y1.6370.000
Compared to industry (Pharmaceutical Retailers)
PeriodCompanyIndustry (mean)+/- 
EOD1.2791.120+0.159
MRQ1.0141.362-0.348
TTM1.2701.468-0.198
YOY1.6251.299+0.326
5Y1.6371.837-0.200
10Y1.6372.907-1.270
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets6,095,014
Total Liabilities4,256,669
Total Stockholder Equity1,766,805
 As reported
Total Liabilities 4,256,669
Total Stockholder Equity+ 1,766,805
Total Assets = 6,095,014

Assets

Total Assets6,095,014
Total Current Assets3,743,173
Long-term Assets2,351,841
Total Current Assets
Cash And Cash Equivalents 479,189
Net Receivables 1,809,954
Inventory 834,700
Other Current Assets 32,786
Total Current Assets  (as reported)3,743,173
Total Current Assets  (calculated)3,156,629
+/- 586,545
Long-term Assets
Property Plant Equipment 839,065
Goodwill 1,052,836
Intangible Assets 135,154
Long-term Assets Other 109,196
Long-term Assets  (as reported)2,351,841
Long-term Assets  (calculated)2,136,250
+/- 215,591

Liabilities & Shareholders' Equity

Total Current Liabilities2,854,453
Long-term Liabilities1,402,216
Total Stockholder Equity1,766,805
Total Current Liabilities
Short Long Term Debt 1,788,031
Accounts payable 696,830
Other Current Liabilities 4,307
Total Current Liabilities  (as reported)2,854,453
Total Current Liabilities  (calculated)2,489,168
+/- 365,285
Long-term Liabilities
Long term Debt 1,190,730
Capital Lease Obligations Min Short Term Debt191,891
Long-term Liabilities  (as reported)1,402,216
Long-term Liabilities  (calculated)1,382,621
+/- 19,595
Total Stockholder Equity
Retained Earnings 567,513
Total Stockholder Equity (as reported)1,766,805
Total Stockholder Equity (calculated)567,513
+/- 1,199,292
Other
Capital Stock206,506
Common Stock Shares Outstanding 206,506
Net Debt 2,499,572
Net Invested Capital 4,745,566
Net Working Capital 888,720
Property Plant and Equipment Gross 839,065



6.2. Balance Sheets Structured

Currency in CNY. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-31
> Total Assets 
3,011,615
3,167,510
3,748,375
3,931,417
4,203,581
4,955,117
5,456,171
5,277,655
6,047,540
6,095,014
6,095,0146,047,5405,277,6555,456,1714,955,1174,203,5813,931,4173,748,3753,167,5103,011,615
   > Total Current Assets 
2,658,767
2,735,352
2,956,850
3,011,405
3,063,745
3,429,018
3,445,323
3,314,075
3,747,440
3,743,173
3,743,1733,747,4403,314,0753,445,3233,429,0183,063,7453,011,4052,956,8502,735,3522,658,767
       Cash And Cash Equivalents 
479,640
500,418
517,372
543,000
450,069
775,716
520,987
649,399
392,531
479,189
479,189392,531649,399520,987775,716450,069543,000517,372500,418479,640
       Short-term Investments 
0
0
0
100,000
0
0
0
0
0
0
000000100,000000
       Net Receivables 
1,411,933
1,441,055
1,456,586
1,399,683
1,506,858
1,474,855
1,603,535
1,565,646
1,711,138
1,809,954
1,809,9541,711,1381,565,6461,603,5351,474,8551,506,8581,399,6831,456,5861,441,0551,411,933
       Inventory 
340,996
357,194
466,956
433,209
573,797
574,290
650,419
629,106
839,928
834,700
834,700839,928629,106650,419574,290573,797433,209466,956357,194340,996
       Other Current Assets 
9,384
11,015
11,745
17,707
13,070
26,068
23,682
24,607
21,184
32,786
32,78621,18424,60723,68226,06813,07017,70711,74511,0159,384
   > Long-term Assets 
352,848
432,158
791,525
920,012
1,139,836
1,526,099
2,010,848
1,963,580
2,300,100
2,351,841
2,351,8412,300,1001,963,5802,010,8481,526,0991,139,836920,012791,525432,158352,848
       Property Plant Equipment 
0
0
0
0
555,314
577,686
631,190
719,810
827,351
839,065
839,065827,351719,810631,190577,686555,3140000
       Goodwill 
0
0
156,860
174,410
232,909
232,909
489,057
717,931
1,052,836
1,052,836
1,052,8361,052,836717,931489,057232,909232,909174,410156,86000
       Intangible Assets 
25,627
25,401
63,329
103,551
101,935
125,585
133,089
138,167
136,380
135,154
135,154136,380138,167133,089125,585101,935103,55163,32925,40125,627
       Long-term Assets Other 
8,979
90,810
0
48,725
38,555
523,345
685,316
198,102
67,734
109,196
109,19667,734198,102685,316523,34538,55548,725090,8108,979
> Total Liabilities 
1,313,447
1,457,176
1,929,544
2,113,011
2,357,971
3,110,837
3,653,046
3,496,006
4,214,968
4,256,669
4,256,6694,214,9683,496,0063,653,0463,110,8372,357,9712,113,0111,929,5441,457,1761,313,447
   > Total Current Liabilities 
1,162,722
1,310,438
1,713,701
1,814,310
1,917,138
2,532,137
2,806,881
2,554,565
2,864,346
2,854,453
2,854,4532,864,3462,554,5652,806,8812,532,1371,917,1381,814,3101,713,7011,310,4381,162,722
       Short Long Term Debt 
617,877
767,433
1,088,023
1,198,109
1,326,629
1,587,896
1,585,505
1,521,447
1,671,646
1,788,031
1,788,0311,671,6461,521,4471,585,5051,587,8961,326,6291,198,1091,088,023767,433617,877
       Accounts payable 
392,780
439,824
448,463
367,639
393,543
490,140
575,225
496,209
719,189
696,830
696,830719,189496,209575,225490,140393,543367,639448,463439,824392,780
       Other Current Liabilities 
9,170
6,013
5,208
1,248
2,729
3,296
3,152
3,211
4,361
4,307
4,3074,3613,2113,1523,2962,7291,2485,2086,0139,170
   > Long-term Liabilities 
150,724
146,738
215,843
298,701
440,832
578,700
846,165
941,441
1,350,623
1,402,216
1,402,2161,350,623941,441846,165578,700440,832298,701215,843146,738150,724
       Long term Debt 
106,000
106,107
117,700
211,456
311,100
454,884
678,047
833,747
1,133,800
1,190,730
1,190,7301,133,800833,747678,047454,884311,100211,456117,700106,107106,000
       Capital Lease Obligations Min Short Term Debt
44,724
40,631
98,143
87,245
129,732
123,816
167,541
105,623
197,364
191,891
191,891197,364105,623167,541123,816129,73287,24598,14340,63144,724
       Long-term Liabilities Other 
0
0
0
0
0
0
578
0
0
0
000578000000
> Total Stockholder Equity
1,698,168
1,710,334
1,724,998
1,723,243
1,738,531
1,735,651
1,741,071
1,747,231
1,766,668
1,766,805
1,766,8051,766,6681,747,2311,741,0711,735,6511,738,5311,723,2431,724,9981,710,3341,698,168
   Common Stock0000000000
   Retained Earnings 
491,853
503,874
518,538
516,854
532,142
529,262
534,682
543,939
563,376
567,513
567,513563,376543,939534,682529,262532,142516,854518,538503,874491,853
   Capital Surplus 0000000000
   Treasury Stock0000000000
   Other Stockholders Equity 0000000000



6.3. Balance Sheets

Currency in CNY. All numbers in thousands.




6.4. Cash Flows

Currency in CNY. All numbers in thousands.




6.5. Income Statements

Currency in CNY. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in CNY. All numbers in thousands.

Gross Profit (+$)
totalRevenue3,903,504
Cost of Revenue-3,326,635
Gross Profit576,869576,869
 
Operating Income (+$)
Gross Profit576,869
Operating Expense-3,757,385
Operating Income146,118-3,180,517
 
Operating Expense (+$)
Research Development7,173
Selling General Administrative345,741
Selling And Marketing Expenses0
Operating Expense3,757,385352,915
 
Net Interest Income (+$)
Interest Income5,304
Interest Expense-63,104
Other Finance Cost-15,659
Net Interest Income-73,458
 
Pretax Income (+$)
Operating Income146,118
Net Interest Income-73,458
Other Non-Operating Income Expenses0
Income Before Tax (EBT)48,553146,118
EBIT - interestExpense = -63,104
34,300
97,404
Interest Expense63,104
Earnings Before Interest and Taxes (EBIT)0111,657
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax48,553
Tax Provision-10,545
Net Income From Continuing Ops38,00838,008
Net Income34,300
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net073,458
 

Technical Analysis of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd. The general trend of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 12.40 < 12.72 < 13.00.

The bearish price targets are: 11.09 > 11.05 > 11.04.

Tweet this
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd. The current macd is 0.10954523.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Daily Moving Average Convergence/Divergence (MACD) ChartHunan Dajiaweikang Pharmaceutical Industry Co.Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd. The current adx is 34.15.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd. The current sar is 12.75.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd. The current rsi is 43.74. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Daily Relative Strength Index (RSI) ChartHunan Dajiaweikang Pharmaceutical Industry Co.Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Daily Stochastic Oscillator ChartHunan Dajiaweikang Pharmaceutical Industry Co.Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd. The current cci is -67.2412924.

Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Daily Commodity Channel Index (CCI) ChartHunan Dajiaweikang Pharmaceutical Industry Co.Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd. The current cmo is -25.33142468.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Daily Chande Momentum Oscillator (CMO) ChartHunan Dajiaweikang Pharmaceutical Industry Co.Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd. The current willr is -91.89189189.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Daily Williams %R ChartHunan Dajiaweikang Pharmaceutical Industry Co.Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd.

Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd. The current atr is 0.54193987.

Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Daily Average True Range (ATR) ChartHunan Dajiaweikang Pharmaceutical Industry Co.Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd. The current obv is 209,101,302.

Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Daily On-Balance Volume (OBV) ChartHunan Dajiaweikang Pharmaceutical Industry Co.Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd. The current mfi is 58.27.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Daily Money Flow Index (MFI) ChartHunan Dajiaweikang Pharmaceutical Industry Co.Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-23CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-31STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-08-07STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-08-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-08-30CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-09-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-09-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-30ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-08STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-11-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-11-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-11-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-11-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.744
Ma 20Greater thanMa 5011.829
Ma 50Greater thanMa 10011.658
Ma 100Greater thanMa 20010.524
OpenGreater thanClose12.160
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd with someone you think should read this too:
  • Are you bullish or bearish on Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd

I send you an email if I find something interesting about Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd.

Receive notifications about Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.